BASi (Bioanalytical Systems, Inc.) is reorganizing its Baltimore Clinical Research Unit (CRU) and its UK operations in order to reduce expenses and to improve operating results for these business units and the corporation. The reorganization will result in a reduction of 25 people over both business units. The company expects to lower expenses by $1 million for the first full year of operation following the re-organization. The Bioanalytical Laboratory associated with the CRU in Baltimore w...